Equities research analysts at StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRX - Get Free Report) in a research note issued on Thursday. The brokerage set a "hold" rating on the software maker's stock.
Separately, Stephens increased their price objective on shares of Veradigm from $7.00 to $13.00 and gave the company an "equal weight" rating in a report on Friday, January 31st.
View Our Latest Analysis on Veradigm
Veradigm Trading Up 1.9 %
NASDAQ MDRX traded up $0.10 during trading hours on Thursday, hitting $5.35. The company's stock had a trading volume of 190,541 shares, compared to its average volume of 1,010,997. The stock has a fifty day moving average of $8.37 and a 200 day moving average of $9.27. Veradigm has a twelve month low of $4.50 and a twelve month high of $11.80.
About Veradigm
(
Get Free Report)
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Recommended Stories
Before you consider Veradigm, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veradigm wasn't on the list.
While Veradigm currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
